Rockwell Medical (RMTI) Return on Capital Employed Growth (3y) (2014 - 2026)
Rockwell Medical (RMTI) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.85 Bn | 32.11 Bn | 1.97 Bn | 1,301.00 |
| 3 | Zoetis | 32.52 Bn | 30.58 Bn | 1.62 Bn | 331.00 |
| 4 | Takeda Pharmaceutical | 27.53 Bn | 23.47 Bn | 4.39 Bn | -667.00 |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn | 480.00 |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.30 Bn | 18.50 Bn | 1.16 Bn | -254.00 |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.42 Bn | 800.70 Mn | 1,342.00 |
| 9 | Elanco Animal Health | 12.59 Bn | 12.16 Bn | 785.00 Mn | 1,902.00 |
| 10 | Rockwell Medical | 28.64 Mn | 4.75 Mn | 2.90 Mn | 3,052.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,052.00 |
| Dec 31, 2025 | 4,146.00 |
| Sep 30, 2025 | 5,153.00 |
| Jun 30, 2025 | 8,585.00 |
| Mar 31, 2025 | 12,847.00 |
| Dec 31, 2024 | 9,423.00 |
| Sep 30, 2024 | 7,762.00 |
| Jun 30, 2024 | 8,315.00 |
| Mar 31, 2024 | 2,618.00 |
| Dec 31, 2023 | 2,271.00 |
| Sep 30, 2023 | 1,305.00 |
| Jun 30, 2023 | 1,049.00 |
| Mar 31, 2023 | 3,933.00 |
| Dec 31, 2022 | 5,077.00 |
| Sep 30, 2022 | 2,883.00 |
| Jun 30, 2022 | -64.00 |
| Mar 31, 2022 | -2,547.00 |
| Dec 31, 2021 | 815.00 |
| Sep 30, 2021 | 4,290.00 |
| Jun 30, 2021 | 46.00 |